Expect to Hear About Renal Protection With Newer Diabetes Meds

You'll hear buzz about using SGLT2 inhibitors (Jardiance, etc) or GLP-1 agonists (Victoza, etc) for renal protection in type 2 diabetes.

We know ACE inhibitors or ARBs slow progression of nephropathy in diabetes patients with hypertension and albuminuria.

Now data suggest Jardiance (empagliflozin) or Invokana (canagliflozin) may provide some renal protection...probably by lowering intraglomerular pressure.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote